The Evolution of Heteroresistance via Small Colony Variants in Escherichia coli Following Long Term Exposure to Bacteriostatic Antibiotics
Gil-Gil, T.; Berryhill, B. A.; Manuel, J. A.; Smith, A. P.; Baquero, F.; Levin, B. R.
Show abstract
Traditionally, bacteriostatic antibiotics are agents able to arrest bacterial growth. Despite being traditionally viewed as unable to kill bacterial cells, when they are used clinically the outcome of these drugs is frequently as effective as when a bactericidal drug is used. We explore the dynamics of Escherichia coli after exposure to two ribosome-targeting bacteriostatic antibiotics, chloramphenicol and azithromycin, for thirty days. The results of our experiments provide evidence that bacteria exposed to these drugs replicate, evolve, and generate a sub-population of small colony variants (SCVs) which are resistant to multiple drugs. These SCVs contribute to the evolution of heteroresistance and rapidly revert to a susceptible state once the antibiotic is removed. Stated another way, exposure to bacteriostatic drugs selects for the evolution of heteroresistance in populations previously lacking this trait. More generally, our results question the definition of bacteriostasis as populations exposed to bacteriostatic drugs are replicating despite the lack of net growth.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens 97%
- Competition between phage-resistance mechanisms determines the outcome of bacterial co-existence 96%
- Treatment history shapes the evolution of complex carbapenem-resistant phenotypes in Klebsiella spp. 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.